In addition, further investigation using a human ACE2 transgenic mouse model infected with SARS-CoV-2 in an animal biosafety level 3 laboratory is warranted to verify the antiviral efficacy of KC and its derivatives as cell entry inhibitors in vivo. Here, ACE2 is linked to keratoconus.